1.Flower O, Smith M: The acute management of intracerebral hemorrhage. Curr Opin Crit Care 2011, 17(2):106–114.
2.Zahuranec DB, Gonzales NR, Brown DL, Lisabeth LD, Longwell PJ, Eden SV, Smith MA, Garcia NM, Hoff JT, Morgenstern LB: Presentation of intracerebral haemorrhage in a community. J Neurol Neurosurg Psychiatry 2006, 77(3):340–344.
3.Zheng H, Chen C, Zhang J, Hu Z: Mechanism and Therapy of Brain Edema after Intracerebral Hemorrhage. Cerebrovasc Dis 2016, 42(3–4):155–169.
4.Keep RF, Hua Y, Xi G: Intracerebral haemorrhage: mechanisms of injury and therapeutic targets. Lancet Neurol 2012, 11(8):720–731.
5.Pouratian N, Kassell NF, Dumont AS: Update on management of intracerebral hemorrhage. Neurosurg Focus 2003, 15(4):E2.
6.Cheng X, Wang H, Liu C, Zhong S, Niu X, Zhang X, Qi R, Zhao S, Zhang X, Qu H et al: Dl–3-n-butylphthalide promotes remyelination process in cerebral white matter in rats subjected to ischemic stroke. Brain Res 2019, 1717:167–175.
7.Garcia JH, Wagner S, Liu KF, Hu XJ: Neurological deficit and extent of neuronal necrosis attributable to middle cerebral artery occlusion in rats. Statistical validation. Stroke 1995, 26(4):627–634; discussion 635.
8.Demers G, Griffin G, De Vroey G, Haywood JR, Zurlo J, Bedard M: Animal research. Harmonization of animal care and use guidance. Science 2006, 312(5774):700–701.
9.MacLellan CL, Silasi G, Poon CC, Edmundson CL, Buist R, Peeling J, Colbourne F: Intracerebral hemorrhage models in rat: comparing collagenase to blood infusion. J Cereb Blood Flow Metab 2008, 28(3):516–525.
10.Wang T, Chen X, Wang Z, Zhang M, Meng H, Gao Y, Luo B, Tao L, Chen Y: Poloxamer–188 can attenuate blood-brain barrier damage to exert neuroprotective effect in mice intracerebral hemorrhage model. J Mol Neurosci 2015, 55(1):240–250.
11.Esen F, Erdem T, Aktan D, Orhan M, Kaya M, Eraksoy H, Cakar N, Telci L: Effect of magnesium sulfate administration on blood-brain barrier in a rat model of intraperitoneal sepsis: a randomized controlled experimental study. Crit Care 2005, 9(1):R18–23.
12.Tang XN, Berman AE, Swanson RA, Yenari MA: Digitally quantifying cerebral hemorrhage using Photoshop and Image J. J Neurosci Methods 2010, 190(2):240–243.
13.Zhou F, Jiang Z, Yang B, Hu Z: Magnolol exhibits anti-inflammatory and neuroprotective effects in a rat model of intracerebral haemorrhage. Brain Behav Immun 2019, 77:161–167.
14.Xi G, Keep RF, Hoff JT: Mechanisms of brain injury after intracerebral haemorrhage. Lancet Neurol 2006, 5(1):53–63.
15.Gong C, Hoff JT, Keep RF: Acute inflammatory reaction following experimental intracerebral hemorrhage in rat. Brain Res 2000, 871(1):57–65.
16.Nguyen HX, O’Barr TJ, Anderson AJ: Polymorphonuclear leukocytes promote neurotoxicity through release of matrix metalloproteinases, reactive oxygen species, and TNF-alpha. J Neurochem 2007, 102(3):900–912.
17.Xu HL, Feng YP: Inhibitory effects of chiral 3-n-butylphthalide on inflammation following focal ischemic brain injury in rats. Acta Pharmacol Sin 2000, 21(5):433–438.
18.Sorokin L: The impact of the extracellular matrix on inflammation. Nat Rev Immunol 2010, 10(10):712–723.
19.Chen S, Zeng L, Hu Z: Progressing haemorrhagic stroke: categories, causes, mechanisms and managements. J Neurol 2014, 261(11):2061–2078.
20.van Rossum D, Hanisch U-K: Microglia. Metabolic Brain Disease 2004, 19(3):393–411.
21.Lin S, Yin Q, Zhong Q, Lv FL, Zhou Y, Li JQ, Wang JZ, Su BY, Yang QW: Heme activates TLR4-mediated inflammatory injury via MyD88/TRIF signaling pathway in intracerebral hemorrhage. J Neuroinflammation 2012, 9:46.
22.Taylor RA, Sansing LH: Microglial responses after ischemic stroke and intracerebral hemorrhage. Clin Dev Immunol 2013, 2013:746068.
23.Kitaoka T, Hua Y, Xi G, Nagao S, Hoff JT, Keep RF: Effect of delayed argatroban treatment on intracerebral hemorrhage-induced edema in the rat. Acta Neurochir Suppl 2003, 86:457–461.
24.Lee ST, Chu K, Jung KH, Kim J, Kim EH, Kim SJ, Sinn DI, Ko SY, Kim M, Roh JK: Memantine reduces hematoma expansion in experimental intracerebral hemorrhage, resulting in functional improvement. J Cereb Blood Flow Metab 2006, 26(4):536–544.
25.Lee ST, Chu K, Sinn DI, Jung KH, Kim EH, Kim SJ, Kim JM, Ko SY, Kim M, Roh JK: Erythropoietin reduces perihematomal inflammation and cell death with eNOS and STAT3 activations in experimental intracerebral hemorrhage. J Neurochem 2006, 96(6):1728–1739.
26.Nakamura T, Keep RF, Hua Y, Park JW, Itano T, Nagao S, Hoff JT, Xi GH: Intracerebral hemorrhage induces edema and oxidative stress and alters N-methyl-D-aspartate receptor subunits expression. Acta Neurochir Suppl 2005, 95:421–424.
27.Wagner KR, Hua Y, de Courten-Myers GM, Broderick JP, Nishimura RN, Lu SY, Dwyer BE: Tin-mesoporphyrin, a potent heme oxygenase inhibitor, for treatment of intracerebral hemorrhage: in vivo and in vitro studies. Cell Mol Biol (Noisy-le-grand) 2000, 46(3):597–608.
28.Wu G, Huang FP: Effects of venom defibrase on brain edema after intracerebral hemorrhage in rats. Acta Neurochir Suppl 2005, 95:381–387.
29.Liew HK, Hsu CW, Wang MJ, Kuo JS, Li TY, Peng HF, Wang JY, Pang CY: Therapeutic benefit of urocortin in rats with intracerebral hemorrhage. J Neurosurg 2012, 116(1):193–200.
30.Hu J, Wen Q, Wu Y, Li B, Gao P: The effect of butylphthalide on the brain edema, blood-brain barrier of rats after focal cerebral infarction and the expression of Rho A. Cell Biochem Biophys 2014, 69(2):363–368.
31.Zhao CY, Lei H, Zhang Y, Li L, Xu SF, Cai J, Li PP, Wang L, Wang XL, Peng Y: L–3-n-Butylphthalide attenuates neuroinflammatory responses by downregulating JNK activation and upregulating Heme oxygenase–1 in lipopolysaccharide-treated mice. J Asian Nat Prod Res 2016, 18(3):289–302.
32.Wu Y, Dong L, Huang Q, Sun L, Liao Y, Tang Y, Wu Y: Multiple functional therapeutic effects of DL–3-n-butylphthalide in the cuprizone model of demyelination. Life Sci 2019.
33.Ye J, Zhai L, Zhang S, Zhang Y, Chen L, Hu L, Zhang S, Ding Z: DL–3-n-butylphthalide inhibits platelet activation via inhibition of cPLA2-mediated TXA2 synthesis and phosphodiesterase. Platelets 2015, 26(8):736–744.
34.Wang XL, Wang ZY, Ling JJ, Zhang YH, Yin J: Synthesis and biological evaluation of nitric oxide (NO)-hydrogen sulfide (H2S) releasing derivatives of (S)–3-n-butylphthalide as potential antiplatelet agents. Chin J Nat Med 2016, 14(12):946–953.
35.Ma F, Gao Y, Qiao H, Hu X, Chang J: Antiplatelet activity of 3-butyl–6-bromo–1(3H)-isobenzofuranone on rat platelet aggregation. J Thromb Thrombolysis 2012, 33(1):64–73.